NO155840C - Analogifremgangsmaate for fremstilling av terapeutisk aktive taurin-derivater. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive taurin-derivater.

Info

Publication number
NO155840C
NO155840C NO82820213A NO820213A NO155840C NO 155840 C NO155840 C NO 155840C NO 82820213 A NO82820213 A NO 82820213A NO 820213 A NO820213 A NO 820213A NO 155840 C NO155840 C NO 155840C
Authority
NO
Norway
Prior art keywords
taurin
derivatives
preparation
therapeutic active
analogy procedure
Prior art date
Application number
NO82820213A
Other languages
English (en)
Norwegian (no)
Other versions
NO820213L (no
NO155840B (no
Inventor
Lars Henrik Andersen
Leif Albin Ingemar Hilden
Original Assignee
Medica Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medica Pharma Co Ltd filed Critical Medica Pharma Co Ltd
Publication of NO820213L publication Critical patent/NO820213L/no
Publication of NO155840B publication Critical patent/NO155840B/no
Publication of NO155840C publication Critical patent/NO155840C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Saccharide Compounds (AREA)
NO82820213A 1980-06-06 1982-01-25 Analogifremgangsmaate for fremstilling av terapeutisk aktive taurin-derivater. NO155840C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8004261A SE434638B (sv) 1980-06-06 1980-06-06 Nya terapeutiska verdefulla taurinderivat och deras framstellning
PCT/FI1981/000037 WO1981003492A1 (fr) 1980-06-06 1981-05-22 Composes chimiques, leur production et leur utilisation dans des medicaments

Publications (3)

Publication Number Publication Date
NO820213L NO820213L (no) 1982-01-25
NO155840B NO155840B (no) 1987-03-02
NO155840C true NO155840C (no) 1987-06-10

Family

ID=20341162

Family Applications (1)

Application Number Title Priority Date Filing Date
NO82820213A NO155840C (no) 1980-06-06 1982-01-25 Analogifremgangsmaate for fremstilling av terapeutisk aktive taurin-derivater.

Country Status (26)

Country Link
US (1) US4556673A (fr)
JP (1) JPS57500877A (fr)
AT (1) AT376206B (fr)
BE (1) BE889100A (fr)
CA (1) CA1165322A (fr)
CH (1) CH647505A5 (fr)
CS (2) CS235088B2 (fr)
DD (1) DD159427A5 (fr)
DE (1) DE3152071C2 (fr)
DK (1) DK155521B (fr)
ES (1) ES502761A0 (fr)
FI (1) FI67214C (fr)
FR (1) FR2486077B1 (fr)
GB (1) GB2093457B (fr)
HU (1) HU184871B (fr)
IE (1) IE51264B1 (fr)
IL (1) IL62824A (fr)
IT (1) IT8122151A0 (fr)
NL (1) NL8120217A (fr)
NO (1) NO155840C (fr)
PL (2) PL128321B1 (fr)
PT (1) PT73061B (fr)
SE (1) SE434638B (fr)
SU (1) SU1097198A3 (fr)
WO (1) WO1981003492A1 (fr)
ZA (1) ZA813387B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE458606B (sv) * 1987-04-10 1989-04-17 Huhtamaeki Oy 2-ftalimidoetansulfon-n-arylamider och foerfarande foer framstaellning av dessa
US5801195A (en) * 1994-12-30 1998-09-01 Celgene Corporation Immunotherapeutic aryl amides
AR016384A1 (es) 1997-07-30 2001-07-04 Smithkline Beecham Corp Inhibidores de caspasas, composiciones farmaceuticas que comprenden dichos inhibidores de caspasas y uso de los inhibidores de caspasas para prepararun medicamento util para el tratamiento de apoptosis y desordenes asociados con excesiva actividad de la convertosa il-1 beta.
US6020358A (en) * 1998-10-30 2000-02-01 Celgene Corporation Substituted phenethylsulfones and method of reducing TNFα levels
AU2006200033B8 (en) * 1998-10-30 2008-09-11 Celgene Corporation Substituted phenethylsulfones and methods of reducing TNF-alpha levels
US6667316B1 (en) 1999-11-12 2003-12-23 Celgene Corporation Pharmaceutically active isoindoline derivatives
US6326388B1 (en) 1999-12-21 2001-12-04 Celgene Corporation Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level
US6699899B1 (en) 1999-12-21 2004-03-02 Celgene Corporation Substituted acylhydroxamic acids and method of reducing TNFα levels
US8030343B2 (en) * 2000-06-08 2011-10-04 Celgene Corporation Pharmaceutically active isoindoline derivatives
US7491634B2 (en) * 2006-04-28 2009-02-17 Asm International N.V. Methods for forming roughened surfaces and applications thereof
EP1401805A1 (fr) * 2001-06-26 2004-03-31 Yissum Research Development Company Of The Hebrew University Of Jerusalem Derives de valproyltaurinamide utilises comme anticonvulsants et agents cns actifs
US7244759B2 (en) 2004-07-28 2007-07-17 Celgene Corporation Isoindoline compounds and methods of making and using the same
CN114539106B (zh) * 2022-03-15 2023-05-02 梯尔希（南京）药物研发有限公司 一种稳定同位素标记的牛磺酰胺盐酸盐的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2184279A (en) * 1937-11-27 1939-12-26 Squibb & Sons Inc Amino-aliphatic sulphonamides and process for preparing them
AT219039B (de) * 1959-05-27 1962-01-10 Geigy Ag J R Verfahren zur Herstellung von neuen Isoindolinderivaten
GB1254414A (en) * 1969-05-08 1971-11-24 Shun-Ichi Naito Novel aminoethanesulfonylamino derivatives and their production
US4093723A (en) * 1976-05-19 1978-06-06 Smithkline Corporation 7-Acyl-3-(sulfonic acid and sulfamoyl substituted tetrazolyl thiomethyl) cephalosporins
ZA76757B (en) * 1975-03-18 1977-01-26 Smithkline Corp New cephalosporin compounds
US4048311A (en) * 1976-01-08 1977-09-13 Smithkline Corporation 7-Acyl-3-(sulfonic acid and sulfamoyl substituted tetrazolyl thiomethyl)cephalosporins
US4066762A (en) * 1976-07-12 1978-01-03 Smithkline Corporation Derivatives of 7-(2-substituted-2-hydroxyiminoacetamido)-3-(1-substituted tetrazol-5-ylthiomethyl-3-cephem-4-carboxylic acid

Also Published As

Publication number Publication date
ES8203342A1 (es) 1982-04-01
NO820213L (no) 1982-01-25
CA1165322A (fr) 1984-04-10
IE811037L (en) 1981-12-06
US4556673A (en) 1985-12-03
PT73061B (en) 1982-07-01
DE3152071C2 (de) 1989-06-15
PL235510A1 (fr) 1982-11-22
PT73061A (en) 1981-06-01
DE3152071T1 (de) 1983-10-20
FI67214B (fi) 1984-10-31
GB2093457A (en) 1982-09-02
CS235091B2 (en) 1985-04-16
IE51264B1 (en) 1986-11-26
SE8004261L (sv) 1981-12-07
CS235088B2 (en) 1985-04-16
FI67214C (fi) 1985-02-11
WO1981003492A1 (fr) 1981-12-10
SE434638B (sv) 1984-08-06
PL128321B1 (en) 1984-01-31
NL8120217A (fr) 1982-08-02
HU184871B (en) 1984-10-29
DD159427A5 (de) 1983-03-09
DK30082A (da) 1982-01-25
IL62824A0 (en) 1981-07-31
SU1097198A3 (ru) 1984-06-07
JPS57500877A (fr) 1982-05-20
IT8122151A0 (it) 1981-06-05
FR2486077A1 (fr) 1982-01-08
IL62824A (en) 1984-07-31
AT376206B (de) 1984-10-25
ATA907681A (de) 1984-03-15
ES502761A0 (es) 1982-04-01
FI821650A0 (fi) 1982-05-11
PL128574B1 (en) 1984-02-29
BE889100A (fr) 1981-12-04
CH647505A5 (de) 1985-01-31
GB2093457B (en) 1984-03-21
FI821650L (fi) 1982-05-11
NO155840B (no) 1987-03-02
DK155521B (da) 1989-04-17
PL231531A1 (fr) 1982-08-30
FR2486077B1 (fr) 1988-08-12
ZA813387B (en) 1982-06-30

Similar Documents

Publication Publication Date Title
NO158099C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO159531C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive karbostyrilderivater.
NO156864C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperinderivater.
NO162022C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive cefemderivater.
NO161117C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporinderivater.
NO163451C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminomethyloxooxazolidinylbenzenderivater.
NO156752C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(1-piperidinylalkyl)-4hpyrido(1,2-a)pyrimidin-4-0n derivater
NO165239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater.
NO165192C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater.
NO166320C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO152129C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater
NO156787C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO814136L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 8-arylalkyl-3-fenyl-3-notropanol-derivater
NO158183C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylfenylamidiner.
NO159654C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive 2-guanidin-4-heteroaryltiazolderivater.
NO161676C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive mitosanderivater.
NO161562C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater.
NO155840C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive taurin-derivater.
NO161559C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive triazolderivater.
NO158941C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater.
NO160079C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-derivater.
NO158739C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater.
NO160511C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklo-butanderivater.
NO160512C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO168478C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylthioacetamido-oxacefalosporinderivater.